Eurofins Scientific (0MV5) Ratios
Eurofins Scientific Ratios
GB:0MV5's free cash flow for Q2 2026 was $384.00M. For the 2026 fiscal year, GB:0MV5's free cash flow was decreased by $-191.00M and operating cash flow was $575.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.09 | 1.16 | 1.45 | 1.31 | 1.25 |
| Quick Ratio | 1.03 | 1.09 | 1.38 | 1.22 | 1.17 |
| Cash Ratio | 0.33 | 0.29 | 0.58 | 0.27 | 0.28 |
| Solvency Ratio | 0.15 | 0.20 | 0.17 | 0.23 | 0.25 |
| Operating Cash Flow Ratio | 0.53 | 0.63 | 0.48 | 0.64 | 0.81 |
| Short-Term Operating Cash Flow Coverage | 2.20 | 4.01 | 2.22 | 13.34 | 11.33 |
| Net Current Asset Value | $ -4.75B | $ -3.05B | $ -2.68B | $ -2.92B | $ -2.34B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.33 | 0.36 | 0.33 | 0.30 |
| Debt-to-Equity Ratio | 1.53 | 0.68 | 0.77 | 0.70 | 0.59 |
| Debt-to-Capital Ratio | 0.61 | 0.40 | 0.44 | 0.41 | 0.37 |
| Long-Term Debt-to-Capital Ratio | 0.55 | 0.33 | 0.36 | 0.36 | 0.31 |
| Financial Leverage Ratio | 3.10 | 2.04 | 2.14 | 2.11 | 2.01 |
| Debt Service Coverage Ratio | 1.68 | 2.57 | 1.87 | 6.82 | 4.82 |
| Interest Coverage Ratio | 4.93 | 4.82 | 4.23 | 7.42 | 7.39 |
| Debt to Market Cap | 0.44 | 0.32 | 0.29 | 0.22 | 0.11 |
| Interest Debt Per Share | 31.10 | 19.73 | 21.03 | 17.82 | 15.28 |
| Net Debt to EBITDA | 3.20 | 2.17 | 2.22 | 1.93 | 1.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 12.29% | 67.79% | 9.52% | 66.82% | 68.00% |
| EBIT Margin | 11.23% | 10.00% | 8.48% | 13.19% | 20.22% |
| EBITDA Margin | 19.86% | 19.88% | 18.68% | 21.97% | 26.02% |
| Operating Profit Margin | 11.22% | 10.45% | 8.39% | 11.67% | 18.98% |
| Pretax Profit Margin | 8.96% | 7.98% | 6.50% | 11.62% | 15.73% |
| Net Profit Margin | 6.51% | 5.85% | 4.76% | 9.09% | 11.65% |
| Continuous Operations Profit Margin | 6.48% | 5.83% | 4.72% | 9.01% | 11.66% |
| Net Income Per EBT | 72.63% | 73.28% | 73.30% | 78.23% | 74.07% |
| EBT Per EBIT | 79.92% | 76.37% | 77.41% | 99.59% | 82.85% |
| Return on Assets (ROA) | 4.32% | 3.73% | 2.85% | 6.05% | 8.39% |
| Return on Equity (ROE) | 13.41% | 7.61% | 6.11% | 12.76% | 16.84% |
| Return on Capital Employed (ROCE) | 9.57% | 8.27% | 6.24% | 9.42% | 17.06% |
| Return on Invested Capital (ROIC) | 6.38% | 5.74% | 4.24% | 7.14% | 12.23% |
| Return on Tangible Assets | 8.42% | 7.73% | 5.60% | 13.15% | 18.11% |
| Earnings Yield | 4.23% | 4.32% | 2.73% | 4.73% | 3.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.75 | 4.61 | 4.03 | 4.20 | 4.25 |
| Payables Turnover | 9.44 | 3.47 | 9.82 | 3.44 | 3.43 |
| Inventory Turnover | 46.04 | 15.78 | 42.40 | 15.30 | 13.94 |
| Fixed Asset Turnover | 2.64 | 2.72 | 2.84 | 3.10 | 3.67 |
| Asset Turnover | 0.66 | 0.64 | 0.60 | 0.67 | 0.72 |
| Working Capital Turnover Ratio | 25.83 | 10.80 | 8.77 | 13.37 | 10.45 |
| Cash Conversion Cycle | 46.15 | -3.03 | 62.04 | 4.56 | 5.52 |
| Days of Sales Outstanding | 76.89 | 79.14 | 90.60 | 86.85 | 85.90 |
| Days of Inventory Outstanding | 7.93 | 23.13 | 8.61 | 23.86 | 26.18 |
| Days of Payables Outstanding | 38.67 | 105.30 | 37.17 | 106.16 | 106.56 |
| Operating Cycle | 84.82 | 102.27 | 99.20 | 110.72 | 112.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.19 | 6.92 | 5.28 | 5.90 | 7.88 |
| Free Cash Flow Per Share | 2.97 | 4.15 | 2.43 | 2.47 | 5.17 |
| Dividend Paid and CapEx Coverage Ratio | 1.49 | 2.11 | 1.37 | 1.33 | 2.33 |
| Capital Expenditure Coverage Ratio | 1.70 | 2.50 | 1.85 | 1.72 | 2.91 |
| Operating Cash Flow Coverage Ratio | 0.24 | 0.37 | 0.26 | 0.34 | 0.55 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.19 | 0.16 | 0.17 | 0.22 |
| Free Cash Flow Yield | 4.76% | 8.41% | 4.11% | 3.69% | 4.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 23.64 | 23.15 | 36.67 | 21.16 | 26.62 |
| Price-to-Sales (P/S) Ratio | 1.54 | 1.35 | 1.75 | 1.92 | 3.10 |
| Price-to-Book (P/B) Ratio | 3.17 | 1.76 | 2.24 | 2.70 | 4.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.99 | 11.89 | 24.32 | 27.11 | 21.04 |
| Price-to-Operating Cash Flow Ratio | 8.67 | 7.13 | 11.18 | 11.36 | 13.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.99 | 0.72 | -0.75 | -0.94 | 0.65 |
| Enterprise Value Multiple | 10.95 | 8.97 | 11.57 | 10.68 | 13.20 |
| Enterprise Value | 15.87B | 12.39B | 14.08B | 15.75B | 23.07B |
| EV to EBITDA | 10.95 | 8.97 | 11.57 | 10.68 | 13.20 |
| EV to Sales | 2.18 | 1.78 | 2.16 | 2.35 | 3.43 |
| EV to Free Cash Flow | 29.67 | 15.68 | 30.10 | 33.08 | 23.30 |
| EV to Operating Cash Flow | 12.26 | 9.40 | 13.83 | 13.86 | 15.28 |
| Tangible Book Value Per Share | -9.78 | -1.28 | -1.09 | -3.08 | -1.74 |
| Shareholders’ Equity Per Share | 19.68 | 28.01 | 26.32 | 24.84 | 24.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.27 | 0.27 | 0.22 | 0.26 |
| Revenue Per Share | 40.53 | 36.47 | 33.77 | 34.87 | 35.08 |
| Net Income Per Share | 2.64 | 2.13 | 1.61 | 3.17 | 4.09 |
| Tax Burden | 0.73 | 0.73 | 0.73 | 0.78 | 0.74 |
| Interest Burden | 0.80 | 0.80 | 0.77 | 0.88 | 0.78 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 2.73 | 2.38 | 3.28 | 1.46 | 1.43 |
Currency in EUR